WinstonWınston
Back
Fisher & Paykel Healthcare Corporation Limited logo

Fisher & Paykel Healthcare Corporation Limited

FPH.AX
58
Medical - Instruments & Supplies · Healthcare
Exchange
Australian Securities Exchange
Winston Score
58
Winston is curious
A decent business — some strong pillars, some weaker.
Data as of Aug 23, 2026 · filings through Mar 31, 2026
How the score breaks down
Quality
Exceptional
Growth
Mixed
Cash Flow
Exceptional
Stability
Exceptional
Valuation
Mixed
Dividends
Weak

Winston Score History

The full picture

Fisher & Paykel Healthcare makes medical devices that help people breathe. Its main products are machines and accessories used in hospitals to treat patients with breathing problems, including those with sleep apnea or respiratory illnesses like pneumonia. The company is based in New Zealand and is one of the leading makers of humidification systems — devices that warm and moisten the air delivered through breathing tubes and masks.

The company sells its products to hospitals, clinics, and home care patients across more than 120 countries, with the United States being its largest market. It earns money through a mix of hardware sales and a recurring "razor-and-blades" model, where hospitals keep buying consumable accessories like masks, tubes, and chambers after the initial device purchase — this repeat-purchase cycle gives the business a durable revenue stream. The key growth driver is rising global demand for respiratory care, but the main risk is currency exposure, since most revenue is earned in US dollars while costs are largely in New Zealand dollars.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

-2.6% YoY

YoY Growth Rate

Revenue declining

EPS Growth

-31.3% YoY

YoY Growth Rate

Earnings declining

Insider Activity

0.4%ownership

Flat

Insider ownership roughly steady over the past year

Cash Position

Cash flow positive

A$513M cash & investments

Quarterly Free Cash Flow

↑ Burn rate improving

Company generates more cash than it spends — no dilution risk from fundraising

Revenue declining

Fisher & Paykel Healthcare Corporation Limited's revenue is actually shrinking. In a growth stock, that removes the core investment thesis. The low Winston Score here may be warranted — unless there's a turnaround story.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
64.8%
Premium pricing power — 64.8% gross margin
Profit after running costs
Operating Margin
29.8%
Excellent — 29.8% operating margin
Return on the money invested
ROCE
30.5%
Exceptional — 30.5% return on capital

ROIC above 25%. Every dollar invested in the business earns more than 25 cents back per year.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
+4.8%
Slow sales growth (+4.8% YoY)
Profit growth
EPS YoY
-11.1%
Earnings shrinking (-11.1% YoY)

Earnings per share down more than 10%. Either a bad year, or a real decline.

How steady the profit is
EPS Consistency
4/8 quarters
Earnings inconsistent quarter-to-quarter

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
142%
Turns 142% of profit into real cash
Spare cash per sale
FCF Margin
21.0%
Converts sales into free cash efficiently (21.0%)

Free cash flow margin above 20%. Out of every $100 in sales, more than $20 is real cash they keep.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
0.03
Conservative — low debt load (0.03)
Covers its interest
Interest Cover
64.84x
Comfortably covers interest (64.8x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
45.4x
no trend
Expensive — P/E 45.4

P/E over 35. The market is pricing in heavy, sustained growth.

Cheaper or dearer next year
P/E vs Forward
+5.4
GROWING
Earnings expected to grow meaningfully — cheaper on forward P/E (45.4 → 40.0)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend
Dividend Yield
1.07%
no trend
Small dividend — 1.07% yield

Modest yield. The bulk of any return needs to come from price appreciation.

Dividend record
Dividend Growth
+2.6%
no trend
Dividend flat

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial